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Abstract
Background: Human adenovirus 7 (HAdV-7) was responsible for a significant number of fatalities during the 2011
community outbreak in Taiwan. The mechanisms underlying the pathogenesis of severe adenovirus infections in
non-immunocompromised individuals remain unclear. Adenovirus pneumonia was associated with pleural effusion
in a number of patients from the 2011 outbreak suggesting that similar to bacterial pneumonia, patients diagnosed
with adenovirus pneumonia who have pleural effusion are more severely and systemically infected, and may have a
more protracted disease course. We hypothesized that the host immunological response determines the severity of
adenoviral infection.
Methods: This retrospective case series study included patients diagnosed with severe lower respiratory tract
infections at the National Cheng Kung University Hospital in southern Taiwan between December 2010 and
October 2011. The main inclusion criteria were 1) presence of multifocal patchy infiltrates, lobar consolidation or
reticular interstitial opacities in chest X-rays, and 2) presence of adenovirus isolated from respiratory specimens.
All patients had adenovirus isolated from respiratory specimens, and were negative for other viruses. Pleural
effusion was confirmed in all patients using chest echography. Clinical features and laboratory data were compared in
patients with (n= 12) and without (n= 15) parapneumonic effusion.
Results: Presence of parapneumonic effusion was significantly associated with a longer febrile duration, more
complicated clinical management, and a greater risk of extrapulmonary involvement, notably hepatitis. Patients
without pleural effusion had significantly higher numbers of WBCs, platelets, and absolute segment cell counts
(ASCs) compared to patients with pleural effusion (all p < 0.05). Patients without pleural effusion had significantly
higher counts of CD4+, CD8+, and CD20+ T cells (all p < 0.05) compared to patients with pleural effusion.
Conclusion: Our data indicated that presence of parapneumonic effusion in adenoviral pneumonia was
associated with longer febrile duration, more complicated clinical management, a greater risk of hepatitis, and
suppression of host cellular immunity. Further prospective, large-scale studies are needed to validate our results.
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Background
Human adenoviruses (HAdVs) have been linked to a
number of respiratory, gastrointestinal, ocular, genitouri-
nary and neurologic diseases [1]. There are currently 60
serotypes of HAdVs identified, which are grouped into 7
species based on their morphologic, immunogenic and
genomic properties [2, 3]. HAdV infections have been
linked to mild upper respiratory tract infections such as
pharyngitis or coryza, as well as to more severe lower re-
spiratory tract infections (LRTIs) such as bronchiolitis,
croup and pneumonia [4]. Approximately one-fifth of all
HAdV infections were shown to be caused by HAdV-7,
which is associated with serious LRTIs [5]. Although
treatment of severe adenovirus infection is mainly sup-
portive, antiviral agents such as acyclovir, ganciclovir,
ribavirin, and cidofovir have been investigated for non-
immunocompromised individuals [6, 7]. Therapeutic
strategies such as extracorporeal membrane oxygenation
(ECMO) with or without high frequency oscillatory ven-
tilation (HFOV) have also been evaluated in patients
with severe disease [8, 9].
Children, immunocompromised individuals, and people
in crowded environments such as military recruits and
hospitalized or institutionalized individuals have been
shown to have a higher susceptibility to HAdV infections,
especially HAdV-7 [10–13]. HAdVs 1, 2 and 5 are usually
implicated in endemic or sporadic cases, while HAdVs 7
and to a lesser extent HAdV-3 have been isolated from ep-
idemics of adenovirus LRTIs in healthy children [11, 14].
HAdV-11 and HAdV-7 were the most frequently identi-
fied pathogens in a 2011 study of community-acquired
pneumonia in Beijing, China [15]. HAdV-7 was also re-
ported as the primary pathogen in an outbreak of severe
LRTI among infants in Shaanxi Province, China in 2009,
and Singapore in 2012 [5, 16]. A number of adenovirus
outbreaks involving HAdV-7, HAdV-3, and HAdV-4 have
been reported from Taiwan between 1999 and 2005
[17, 18]. The largest reported community outbreak
which occurred in Taiwan in 2011 involved co-
circulating HAdV-3 and HAdV-7 [19]. Although the
2011 outbreak was associated with HAdV-3 as well as
HAdV-7, patients infected with HAdV-7 had a higher
fatality rate [20]. HAdV-7 isolated from the 2011 out-
break was shown to have the highest homology with
HAdV-7d and HAdV-7d2, strains which had not been
seen in Taiwan prior to 2011 [19].
Cellular immunity plays an important role in viral in-
fections, and severe adenovirus infections are commonly
seen in immunocompromised individuals. The mecha-
nisms underlying the pathogenesis of severe adenovirus
infections in non-immunocompromised individuals re-
main unclear. Production of chemokines and cytokines
in response to HAdV-7 infection was shown to damage
lung tissue, and result in recruitment of inflammatory
cells such as neutrophils, monocytes and lymphocytes
[21, 22]. Interestingly, a recent report reviewed 19 stud-
ies which evaluated immunocompetent patients with
adenovirus pneumonia and showed that more than half
the patients were lymphopenic [23]. A recent retrospect-
ive study also showed that non-immunocompromised
patients with severe adenovirus pneumonia had lower
hemoglobin levels, leucopenia, thrombocytopenia and
elevated liver enzymes, suggesting a distinctive mech-
anism of immunopathogenesis which may contribute to
the severity of the infection [7].
We hypothesized that the host immunological re-
sponse determines the severity of adenoviral infection.
Additionally, we observed that adenovirus pneumonia
was associated with pleural effusion in a number of pa-
tients from the 2011 outbreak. We hypothesized that
similar to bacterial pneumonia, patients diagnosed with
adenovirus pneumonia who have pleural effusion are
more severely and systemically infected, and may have a
more protracted disease course. In this retrospective
case series study, we evaluated the clinical manifesta-
tions of adenoviral pneumonia in a convenience sample
of 27 patients from the 2011 outbreak in South Taiwan
and compared clinical features and laboratory data be-
tween patients with or without parapneumonic effusion.
Methods
Materials
Blood cultures were done using the BACTEC Fx System
(BD Biosciences, USA). Urine pneumococcal antigen
tests were done with the BinaxNOW® Streptococcus
pneumoniae Antigen Card (Alere Ltd, Stockport, UK),
and urine Legionella antigen tests were done with the
BinaxNOW Legionella Urinary Antigen Card (Alere Ltd,
Stockport, UK). The Cryptococcus antigen test was done
with the CALAS® Cryptococcal Antigen latex agglutin-
ation system (Meridian Bioscience, Inc, Cincinnati,
Ohio, USA). Mycoplasma antibodies were detected
using the Serodia Myco II gelatin particle agglutination
kit (Fujirebio, Tokyo, Japan). The influenza rapid test
was performed with the Directigen Flu A + B test
(Directigen; BD Diagnostic Systems, Sparks, MD.)
CDC-validated FDA-approved real time RT-PCR assays
were used to detect human influenza virus (CDC influ-
enza division, USA). The respiratory syncytial virus (RSV)
antigen test was a direct fluorescent-antibody assay (DFA)
by Diagnostic Hybrids Inc. (DHI; Athens, OH).
Patients
This retrospective, single-center, observational case
series included a total of 27 patients who presented
with severe adenovirus LRTIs at the National Cheng
Kung University (NCKU) Hospital in southern Taiwan
between December 2010 and October 2011. Inclusion
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criteria were 1) presence of multifocal patchy infiltrates,
lobar consolidation or reticular interstitial opacities in
chest X-rays, and 2) presence of adenovirus isolated
from respiratory specimens. Pleural effusion and diag-
nosis of adenoviral pneumonia was confirmed in all
study patients using chest echography, which is an
ultrasound technique. Chest echography at the NCKU
hospital is mainly performed by senior pediatric resi-
dents with at least three years of pediatric training. The
results are subsequently confirmed by the attending
pediatrician and another pediatric chest specialist.
All throat swabs were examined for the presence of in-
fluenza virus using PCR assays, and for the presence of
RSV antigen using a direct fluorescent-antibody assay.
All specimens were negative for influenza and RSV.
Co-infections were excluded using blood cultures,
sputum cultures, pleural effusion cultures, the urine
pneumococcal antigen test, the urine Legionella antigen
test, the influenza rapid test, the RSV rapid test, PCR
assay for influenza and the Cryptococcus and Myco-
plasma tests. Data for presence of Mycoplasma anti-
bodies were available for 21 patients (19 patients were
negative and 2 patients were positive for Mycoplasma).
Data for Legionella antibodies were only available for 3
patients, all of whom were negative for Legionella. Only
two cases with significantly elevated levels of myco-
plasma antibody presented with simple adenovirus
pneumonia. Since our results would not have changed
even if we had excluded these two cases, we retained
these two cases in the adenovirus pneumonia without
pleural effusion group. All other viral cultures only
showed the presence of adenovirus. Although the anti-
biotic regimen varied from patient to patient, most pa-
tients were on ampicillin/sulbactam. All patient data were
recorded soon after hospitalization. It is important to note
that at the NCKU Hospital, all pediatric patients except
those with walking/atypical pneumonia (caused by myco-
plasma) are hospitalized for evaluation and treatment, and
their medical data are accessible using administrative hos-
pital data. This decreases the likelihood of selection bias
within this sample of hospitalized patients.
This study sample was a convenience sample. Patients
with adenovirus pneumonia usually have prolonged fever
and severe respiratory symptoms, which increases the like-
lihood of seeking medical care. Most patients were referred
by their local practitioners if their fever did not subside on
the 3rd or 4th day. Our hospital is one of the biggest
and largest pediatric tertiary referral centers in southern
Taiwan, and even when the study cases are sampled by
convenience, they are likely to closely reflect the population
of patients hospitalized with severe adenoviral infection.
This study was approved by the Institutional Review
Board of the National Cheng Kung University (NCKU)
Hospital.
Statistical analysis
Continuous data for the two groups of patients (patients
with or without pleural effusion) were represented as ei-
ther (i) mean ± SD and compared using the two-sample
t-test if the data followed normal distribution or (ii) me-
dian (IQR: 1st, 3rd quartiles) and compared using the
Mann-Whitney U test if the data didn’t follow normal
distribution. Categorical data were represented as n (%)
in the two groups of patients and compared using the
Fisher’s exact test. All statistical assessments were two-
tailed and p values <0.05 were considered significant. All
statistical analyses were carried out with IBM SPSS stat-
istical software version 22 for Windows (IBM Corp.,
New York, USA).
Results
This case series included a total of 27 patients who were
admitted to the NCKU hospital with adenovirus pneu-
monia during the 2011 epidemic. Figure 1 represents the
number of patients per month from whom adenoviruses
were isolated at the NCKU hospital between 2007 and
2012.
In our present study, 12 study patients (44.4%) were
classified into the pleural effusion group and 15 patients
(55.6%) were classified into the non-pleural effusion
group. The clinical characteristics of the two groups are
summarized in Table 1. There were no significant differ-
ences in clinical characteristics between patients with
and without pleural effusion (all p > 0.05). The mean age
of the patients was 10 years (SD = 12.1, range: 1 to
42 years).
The study population comprised 17 males (63%). Two
patients (7.4%) had underlying disease. Study patients
had an average of 6 days of fever at admission (SD = 3,
range: 1 to 14 days). The radiological findings showed
that 12 patients (44.4%) had multifocal infiltrates, 13
patients (48.1%) had lobar pneumonia, and 2 patients
(7.4%) had pneumonitis. Additionally, 6 patients (22.2%)
had chest tube replacement. Genotype analysis showed
that 15 patients (55.6%) had genotype 3 s, whereas 9 pa-
tients (33.3%) had genotype 7 s. Genotype data were not
available for 3 patients.
Clinical findings in the two study groups are pre-
sented in Table 2. Patients without pleural effusion had
a significantly lower number of febrile days (7 days vs.
10.5 days; p = 0.022), a significantly lower number of
hospital days (5 days vs. 11 days; p = 0.002), a signifi-
cantly lower ICU admission rate (9 out of 10 patients
admitted to the ICU had pleural effusion; p = 0.001),
and a significantly lower rate of oxygen requirement
(10 out of 13 patients who required oxygen had pleural
effusion; p = 0.002) compared to patients without
pleural effusion.
Shen et al. BMC Infectious Diseases  (2017) 17:196 Page 3 of 8
A comparison of laboratory findings in the two study
groups is presented in Table 3. Our data showed that pa-
tients without pleural effusion had significantly higher
WBC counts, platelet counts, and ASC compared to pa-
tients with pleural effusion (all p < 0.05).
White blood cell immunophenotypes were analyzed
in patients with adenovirus pneumonia with and with-
out pleural effusion. Data from 3 patients without
pleural effusion and 5 patients with pleural effusion are
presented in Table 4. Patients without pleural effusion
had significantly higher counts of CD4+ (p = 0.034),
CD8+ (p = 0.031), and CD20+ T cells (p < 0.004).
Discussion
In this retrospective case series study, we analyzed the
data of 27 patients with adenovirus pneumonia from the
2011 outbreak in Taiwan, and compared clinical features
and laboratory data between patients with or without
parapneumonic effusion using pleural effusion as a
marker for disease severity. Our data showed that the
presence of parapneumonic effusion was significantly
associated with a longer febrile duration, more compli-
cated clinical management, and a greater risk of extra-
pulmonary involvement, notably hepatitis, compared to
patients without parapneumonic effusion. Patients with
Fig. 1 Number of patients per month from whom adenoviruses were isolated at the NCKU hospital during 2007–2012/July. The number above
the circle means the total number of patients for the given month
Table 1 Clinical characteristics of patients with adenovirus pneumonia admitted to the NCKU hospital during the 2011 epidemic
(N = 27)
Variables Total (n = 27) Adenoviral pneumonia without
pleural effusion (n = 15)
Adenoviral pneumonia with
pleural effusion (n = 12)
P value
Age, years 4.1 (2.6 , 16.0) 3.7 (2.0 , 5.1) 5.6 (3.0 , 19.4) 0.213
Sex, males (%) 17 (63.0) 8 (53.3) 9 (75.0) 0.424
Underlying disease 2 (7.4) 1 (6.7) 1 (8.3) 1.000
Fever days at admission 6 (4 , 7) 5 (3 , 7) 7 (5 , 9.5) 0.092
Radiological findings
Multifocal infiltrates 12 (44.4) 7 (46.7) 5 (41.7) 1.000
Lobar pneumonia 13 (48.1) 6 (40.0) 7 (58.3) 0.449
Pneumonitis 2 (7.4) 2 (13.3) 0 (0.0) 0.487
Chest tube replacement 6 (22.2) 0 (0.0) 6 (50.0) NA
Genotypes 0.303
3S 15 (55.6) 10 (66.7) 5 (41.7)
7S 9 (33.3) 3 (20) 6 (50)
Lost 3 (11.1) 2 (13.3) 1 (8.3)
Data were expressed as median (IQR: 1st, 3rd quartiles) for continuous variables and n (%) for categorical ones
Differences between patients with and without pleural effusion were compared using the Mann-Whitney U test for continuous variables and Fisher’s exact test for
categorical ones
There were no significant differences between patients with and without pleural effusion
NA not assessed
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pleural effusion had significantly fewer leukocytes and
T lymphocytes (CD4 +, CD8+, or CD20+) compared to
patients without pleural effusion, suggesting that the
presence of parapneumonic effusion in adenoviral
pneumonia was a hallmark of depressed host cellular
immunity.
It has been reported that approximately 40% of chil-
dren hospitalized with pneumonia had pleural effusion
[24, 25]. Pleural effusion in children is most frequently
seen as a complication of bacterial pneumonia, while
viral pneumonia is more frequently associated with acute
respiratory distress syndrome (ARDS) than with pleural
effusion. The relationship between pleural effusion and
viral pneumonia has not been fully explored. The preva-
lence rates of pleural effusion in influenza pneumonia
and RSV pneumonia are 19.1%, and 6%, respectively [26,
27]. There are limited reports regarding the prevalence
of pleural effusion in adenovirus pneumonia, with esti-
mates ranging from 37.5 to 48%. In pneumonia associ-
ated with H1N1 influenza, patients with pleural effusion
had more lymphopenia, higher C-reactive protein level
and more need for oxygen therapy compared to the
non-effusion group. These data suggested that there was
a significant difference in immunologic response be-
tween patients in the pleural effusion group and those in
the non-pleural effusion group.
Table 2 Clinical findings in patients with adenovirus pneumonia admitted to the NCKU hospital during the 2011 epidemic based on
the presence or absence of pleural effusions
Variables Total (n = 27) Adenoviral pneumonia without
pleural effusion (n = 15)
Adenoviral pneumonia with
pleural effusion (n = 12)
P value
Clinical symptoms other than respiratory tracts
Conjunctivitis 1 (3.7) 0 (0.0) 1 (8.3) NA
Gastroenterocolitis 11 (40.7) 7 (46.7) 4 (33.3) 0.696
Hepatitis 8 (29.6) 0 (0.0) 8 (66.7) NA
Encephalitis 1 (3.7) 0 (0.0) 1 (8.3) NA
Total febrile days 7 (6 , 11) 7 (5 , 9) 10.5 (7 , 12.8) 0.022*
Hospitalization days 7 (5 , 12) 5 (4 , 8) 11 (7.5 , 14.5) 0.002*
Duration for fever after admission, days 2 (0 , 4) 1 (0 , 4) 3.5 (0.3 , 4.8) 0.277
Patients with ICU admission 10 (40.7) 1 (6.7) 9 (75.0) 0.001
ICU hospitalization daysa 6.0 (3.8 , 10.25) 9 (NA) 6 (3.5 , 11.5) NA
Patients with ventilator 3 (11.9) 1 (6.7) 2 (16.7) 0.569
Patients with oxygen requirement 13 (48.1) 3 (20.0) 10 (83.3) 0.002*
Days of oxygen requirement 5 (4 , 12) 5 (4 , 14) 5 (4 , 13.3) 0.931
Data were expressed as median (IQR: 1st, 3rd quartiles) for continuous variables and n (%) for categorical ones
Difference between patients with and without pleural effusion were compared using the Mann-Whitney U test for continuous variables and Fisher’s exact test for
categorical ones
NA not assessed
*p < 0.05, indicates a significant difference between patients with and without pleural effusion
aOf 10 patients requiring ICU hospitalization, one patient had adenovirus pneumonia without pleural effusion, and nine patients had adenovirus pneumonia with
pleural effusion
Table 3 Laboratory examinations of patients with adenovirus pneumonia based on the presence or absence of pleural effusion
(N = 27)
Variables Total (n = 27) Adenoviral pneumonia without
pleural effusion (n = 15)
Adenoviral pneumonia with
pleural effusion (n = 12)
P value
WBC count, cells/mm3 9674 ± 3427 10926.7 ± 3043.6 8108.3 ± 3340.8 0.031*
Platelet, 103 cells/mm3 236 ± 108 285.1 ± 108.2 175.8 ± 75.5 0.007*
ANC, cells/mm3 7451 ± 3173 8738.4 ± 2879.7 6291.7 ± 3255.9 0.090
ASC, cells/ mm3 6039 ± 2674 7083.4 ± 2370.8 4733.9 ± 2531.2 0.020*
ABC, cells/ mm3 1397 ± 912 1268.1 ± 903.8 1557.8 ± 934.7 0.423
ALC, cells/ mm3 1444 ± 1064 1677.3 ± 1204.2 1152.2 ± 814.9 0.209
CRP level, mg/L 68.9 (38.9 , 139.5) 62.9 (35.6 , 79.9) 110.8 (42.0 , 247.2) 0.082
Data were represented as mean ± SD and compared using two-sample t-test if data followed normal distribution; or median (IQR: 1st, 3rd quartiles) and compared
using the Mann-Whitney U test if data didn’t follow normal distribution
ANC absolute neutrophil counts, ABC absolute band form cell counts, ASC absolute segment cell counts, ALC absolute lymphocyte counts
*p < 0.05, indicates a significant difference between patients with and without pleural effusion
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A total of 674 adenovirus isolates were identified dur-
ing the 2011 outbreak, of which 215 cases were hospital-
ized. Our data identified 27 cases with severe adenovirus
pneumonia. In contrast, 80% of hospitalized patients
were diagnosed with mild to moderate upper respiratory
tract infections. Our present results, showing that pa-
tients with pleural effusion had more severe disease
compared to patients without pleural effusion, were con-
sistent with previous studies analyzing the 2011 Taiwan
outbreak, which showed that patients with severe infec-
tion had a longer duration of fever and higher incidence
of LRTI involvement compared to patients with non-
severe infection [19, 20]. Almost half the patients with
severe infection from these and other studies exhibited
LRTI symptoms such as pneumonic consolidation,
pleural effusion, dyspnea, rales and wheezing [19].
Complications such as respiratory failure, acute respira-
tory distress syndrome (ARDS) and hypotension are
also hallmarks of severe adenovirus infections [20, 28,
29]. Indeed, the presence of co-morbidities such as
pleural effusion requiring drainage, respiratory distress,
wheezing and gastroenteritis have been shown to be
risk factors for severe adenovirus pneumonia [30, 31].
Our study showed that although there was no signifi-
cant difference between the two groups in the number
of days of oxygen requirement, a significantly higher
number of patients with pleural effusion required oxy-
gen compared to the group without pleural effusion.
The innate immune response has been shown to play
an important role in the host response to HAdV infec-
tions [32, 33]. The initial inflammation in adenovirus
pneumonia has been shown to begin with a neutrophilic
interstitial infiltrate, followed by appearance of mono-
cytes, then a lymphocytic infiltrate and release of IL-8
and IL-6 [21]. Other studies reported that intravenous
injection of large doses of adenovirus caused leukopenia
in non-human primates, humans and hamsters, with a
significant decrease in the number of CD3+, CD4+ and
CD8+ cells at 1 day post-challenge [34–36]. It has been
suggested that adenovirus infections in immunocompe-
tent individuals could result from inhibition of cytokine
production, suppression of T cell function, and inhibition
of major histocompatibility complex (MHC) expression by
virulent strains like HAdV-3 and HAdV-7 [37]. Recom-
binant adenovirus 35 (rAd35) has been shown to inhibit
DC-induced activation of CD4+ cells by specifically bind-
ing to CD46 on the surface of T cells and suppressing pro-
liferation and cytokine production in memory cells as well
as in total CD4+ cells [38]. Our study data suggested that
the presence of parapneumonic effusion in adenoviral
pneumonia was significantly associated with depression of
host cellular immunity, and were consistent with previous
findings that patients with severe infection more fre-
quently had leukopenia and thrombocytopenia compared
to patients with non-severe infection [19, 20]. It is import-
ant to note that in our study, lymphocyte counts were
calculated only for cases where data for immune cell sub-
populations were available (n = 5), whereas ALC numbers
were calculated for all cases. The lymphocyte counts were
therefore different from ALC counts. Since inflammation
of the respiratory tract is typically associated with upregu-
lation of ALCs, lymphocytes and T cells, we suggest that
depression of host cellular immunity during parapneumonic
effusion could be because of re-distribution of these im-
mune cells. Our data indicated that patients without
pleural effusion had significantly higher WBC counts
compared to patients with pleural effusion. It will be inter-
esting to validate our findings in a larger sample size to
understand the association between disease severity and
leukocytosis. Based on our data, it is likely that preventive
measures for opportunistic infections may be effective
when patients with adenovirus pneumonia present with
parapneumonic effusion.
In addition to lung injury, severe adenovirus infection
has been reported to also result in liver injury, with ele-
vated levels of serum lactate dehydrogenase (LDH) and
aspartate aminotransferase (AST) correlating with severity
of adenovirus infection [20, 39]. In our present study, the
incidence of hepatitis was significantly higher in patients
with pleural effusion compared to patients without pleural
effusion, suggesting the presence of a more severe sys-
temic inflammatory process in these patients.
Table 4 Immune phenotype of white blood cells of patients with adenovirus pneumonia based on the presence or absence of
pleural effusion (n = 8)
Variables Adenoviral pneumonia without
pleural effusion (n = 3)
Adenoviral pneumonia with
pleural effusion (n = 5)
P value
WBC count, cells/mm3 13500 (11500 , 18600) 6400 (5400 , 12800) 0.089
Lymphocyte counts, cells/mm3 2418 (1150 , 2835) 1802 (403 , 2530) 0.451
CD4+ T cells, cells/mm3 597 (465 , 1321) 130 (102 , 319) 0.034*
CD8+ T cells, cells/ mm3 601 (284 , 621) 108 (70 , 286) 0.031*
CD20+ T cells, cells/ mm3 439 (216 , 445) 35 (14 , 112) 0.004*
NK cells, cells/ mm3 77 (15 , 295) 23 (2 , 65) 0.393
*p < 0.05, indicates a significant difference between patients with and without pleural effusion
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Conclusions
To the best of our knowledge, this study is the first to
analyze T-cell profiles in relation to the presence of
parapneumonic effusion in patients with adenoviral
pneumonia. Our data were consistent with previous
findings from the 2011 community outbreak in Taiwan,
and indicated that severity of adenovirus infection corre-
lated positively with suppression of T-cell immunity. Al-
though the mechanism remains unclear, it is likely that
T-cell depression may be due to direct inhibition by
adenovirus, or non-specific inhibition associated with
immunoparalysis at late sepsis. Further prospective,
large-scale studies are needed to further characterize the
clinical outcomes and risks for subsequent infections
among these patients. An important drawback of this
study was the small sample size. Therefore, although it
was previously reported that patients infected with
HAdV-7 had a higher mortality rate in the 2011 out-
break [20], the sample size of this study precluded our
ability to stratify our study patients based on their
HAdV-3 or HAdV-7 status for statistical comparison.
Additionally, there were no deaths over the course of
our study period. However, even with limited case num-
bers, we found a significant difference in immune pro-
files between patients with simple pneumonia and those
with pleural effusion. It will be interesting to evaluate
dynamic changes in immune cell profiles through the
course of infection to better understand the interaction
between viral and immune cells.
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